Sign in
4

Changes in Ownership

NOVAVAX INC Filed Acc 0001209191-21-067151

President, R&D sold 2,083 shares at an average $218.07 ($454,247)

  • President, R&D gave up 647 shares (to pay taxes)
  • President, R&D acquired 3,460 shares (option exercise)
  • President, R&D returned 38 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Glenn Gregory M · President, R&D

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-26 Exercise or conversion : show line 1 in the form +2,083 $5.95 $12,394 6,144 D
2021-11-26 Sale : show line 2 in the form −185 $215.00 $39,776 5,959 D
2021-11-26 Sale : show line 3 in the form −260 $216.19 $56,209 5,699 D
2021-11-26 Sale : show line 4 in the form −331 $217.36 $71,946 5,368 D
2021-11-26 Sale : show line 5 in the form −626 $218.25 $136,627 4,742 D
2021-11-26 Sale : show line 6 in the form −412 $219.25 $90,333 4,330 D
2021-11-26 Sale : show line 7 in the form −155 $220.22 $34,134 4,175 D
2021-11-26 Sale : show line 8 in the form −114 $221.24 $25,222 4,061 D
Open-market sales · 2,083 sh · avg $218.07 · $454,247

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-11-26 Exercise or conversion : show line 12 in the form Stock Option (Right to Buy) −2,083 $5.95 2029-09-26 2,083 45,834 D
2021-11-26 Exercise or conversion : show line 13 in the form Stock Appreciation Right −1,377 $5.95 2029-09-26 1,377 30,296 D
Loading xslF345X03/doc4.xml…